Skip to main content

Table 1 Description of modeled scenarios

From: Achieving malaria testing and treatment targets for children under five in Mozambique: a cost-effectiveness analysis

Scenario

Description

Status quo

No changes to the current situation

1: 100% testing rate

Full compliance with national testing guidelines, which includes testing of all febrile or suspected cases with RDTs (i.e., phase-out of microscopy)

2: Increase testing rate by 10%

Increase overall testing rate by 10% (from 47 to 52%) and the RDT testing rate by 10% (from 69 baseline to 76%) across all types of providers*

3: 100% treatment rate

Full compliance with national treatment guidelines, which includes 100% treatment of all test-positive cases and treatment of uncomplicated cases with AL and severe cases with IV/IM artesunate

4: Increase treatment rate by 10%

Increase overall treatment rate by 10% (from 99 to 100%) and increase ACT treatment rate by 10% (from 84 to 92%)*

5: Scenarios 1 and 3

Combination of Scenarios 1 and 3; full compliance with testing and treatment guidelines, 100% testing with RDTs, and 100% treatment with AL for uncomplicated cases and IV/IM AS for severe cases

6: Scenarios 2 and 4

Combination of Scenarios 2 and 4; increase in overall testing and treatment rates by 10%, RDT testing rate by 10%, and ACT treatment rate by 10%

  1. *The increase in testing and treatment rates can be a function of both supply and demand factors, including stockouts, staff training, and quality assurance and improvement activities
  2. AL, artemether-lumefantrine; AS, artesunate; IM, intramuscular; IV, intravenous; RDT, rapid diagnostic test